Terconazole

• Description :

  Terconazole is a broad-spectrum antifungal medication for the treatment of vaginal yeast infection.

• Product Name Alternative :

  R42470

• UNSPSC :

  12352005

• Hazard Statement :

  H315, H319, H335, H413

• Target :

  Fungal

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/Terconazole.html

• Purity :

  99.93

• Solubility :

  DMSO : ≥ 30 mg/mL

• Smiles :

  CC(N1CCN(C2=CC=C(OC[C@@H]3O[C@@](CN4N=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)C

• Molecular Formula :

  C26H31Cl2N5O3

• Molecular Weight :

  532.46

• Precautions :

  H315, H319, H335, H413

• References & Citations :

  [1]Tolman EL, et al. Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother. 1986 Jun;29 (6) :986-91.|[2]Van Cutsem J, et al. The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol. 1991 Oct;165 (4 Pt 2) :1200-6.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• CAS Number :

  [67915-31-5]